Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Coffee Day Enterprises Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-07-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539436 COFFEEDAY

1
Podcast | Sensex ends at record high, Nifty manages to close above 11K; RIL surges 4%

2018-07-12 moneycontrol
Driven by positive global cues as well as a good start to earnings season, backed by TCS, pushed the markets to fresh records on Thursday. Investors looked to cash in on the bullish momentum as buying was visible across sectors. Having said that, the Street closed off the day's high points.
500325 533271 RELIANCE 539436 COFFEEDAY ASHOKA 533278 HDB 500180 RIGD HDFCBANK CLNDY COALINDIA RLNIY

1
An evening walk down Dalal Street | Sensex ends at record high, Nifty manages to close above 11K; RIL surges 4%

2018-07-12 moneycontrol
Driven by positive global cues as well as a good start to earnings season, backed by TCS, pushed the markets to fresh records on Thursday. Investors looked to cash in on the bullish momentum as buying was visible across sectors. Having said that, the Street closed off the day's high points.
500325 533271 RELIANCE 539436 COFFEEDAY ASHOKA 533278 HDB 500180 RIGD HDFCBANK CLNDY COALINDIA RLNIY

0
Cafe Coffee Day operator surges 3% after arm ties up with UberEats to deliver products

2018-07-12 moneycontrol
Shares of Coffee Day Enterprises, the operator of Café Coffee Day, gained around 3 percent in morning trade after its subsidiary tied up with UberEats to distribute food products.
539436 COFFEEDAY

0
Coffee Day Enterprises Limited - Updates

2018-07-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539436 COFFEEDAY

0
Coffee Day Enterprises Q4 profit rises 36% at Rs34.5 crore

2018-05-17 livemint
New Delhi: Coffee Day Enterprises, which runs coffee chain under brand name Cafe Coffee Day, on Thursday reported a 36.36% rise in consolidated net profit at Rs34.5 crore for the quarter ended March 2018.
539436 COFFEEDAY

0
Coffee Day Enterprises Q4 net up 36% at Rs 34.5 cr

2018-05-17 moneycontrol
Coffee Day Enterprises, which runs coffee chain under brand name Cafe Coffee Day, today reported a 36.36 percent rise in consolidated net profit at Rs 34.5 crore for the quarter ended March 2018.
539436 COFFEEDAY

0
Coffee Day Enterprises Limited - Financial Result Updates

2018-05-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539436 COFFEEDAY

0
Coffee Day Enterprises Limited - Investor Presentation

2018-05-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539436 COFFEEDAY

0
Mindtree investor V.G. Siddhartha sees firm doubling revenue by 2023

2018-05-02 livemint
Bengaluru: V. G. Siddhartha, the founder of Café Coffee Day Ltd who holds a fifth of the equity in Mindtree Ltd, said he remains committed to the information technology (IT) outsourcing company, which according to him is expected to more than double its revenue to $2 billion by 2023.
539436 COFFEEDAY MNDQY

0
Chai Point parent in talks to raise $20 million from Paragon, others

2018-04-08 livemint
Bengaluru: Mountain Trails Foods Pvt. Ltd, which owns the Chai Point chain of tea and snacks stores, is in advanced discussions to raise about $20 million in Series C funding from new investors such as private equity firm Paragon Partners and existing investors that include Saama Capital India Advisors Llp, according to two people familiar with the talks.
539436 COFFEEDAY

0
Coffee Day Enterprises Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539436 COFFEEDAY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...